Abstract: OBJECTIVES: To examine the hospital at home programs for cancer patients globally, and determine the services, target population, model of care, and program characteristics. Additionally, we assessed their applicability and identified barriers and...
Abstract: OBJECTIVES: Patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (aNSCLC) are at high risk of developing brain metastases (BM), thus entailing significant clinical and economic burden. The aim of this study was to...
Abstract: OBJECTIVES: To evaluate the cost-effectiveness of upadacitinib in patients with moderately to severely active ulcerative colitis (UC), who have had an inadequate response, lost response or were intolerant to either conventional therapy (bio-naive) or a...
Abstract: OBJECTIVES: Juvenile idiopathic arthritis is the most common chronic rheumatic disease in childhood. In this light, the aim of the present study was to perform a cost-comparison analysis of tofacitinib compared to currently marketed available treatment for...
Abstract: OBJECTIVES: To evaluate the cost-effectiveness of pemigatinib compared to oxaliplatin-L-folinic-acid and fluorouracil plus active symptom control (mFOLFOX+ASC) and ASC alone for the treatment of patients with advanced or metastatic cholangiocarcinoma (CCA)...